ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354 | -13.0% | 17,000 | 0.0% | 0.12% | -10.2% |
| Q2 2023 | $407 | +27.2% | 17,000 | 0.0% | 0.13% | +17.4% |
| Q1 2023 | $320 | +18.1% | 17,000 | 0.0% | 0.11% | +12.4% |
| Q4 2022 | $271 | -99.9% | 17,000 | 0.0% | 0.10% | -4.9% |
| Q3 2022 | $278,000 | +15.8% | 17,000 | 0.0% | 0.10% | +21.4% |
| Q2 2022 | $240,000 | -41.7% | 17,000 | 0.0% | 0.08% | -22.9% |
| Q1 2022 | $412,000 | +3.8% | 17,000 | 0.0% | 0.11% | +14.7% |
| Q4 2021 | $397,000 | +38.8% | 17,000 | -1.2% | 0.10% | +26.7% |
| Q3 2021 | $286,000 | -37.0% | 17,200 | -7.5% | 0.08% | -35.9% |
| Q2 2021 | $454,000 | -1.1% | 18,600 | +4.5% | 0.12% | -8.6% |
| Q1 2021 | $459,000 | -51.8% | 17,800 | 0.0% | 0.13% | -56.3% |
| Q4 2020 | $952,000 | +35.0% | 17,800 | +4.1% | 0.29% | +18.1% |
| Q3 2020 | $705,000 | – | 17,100 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |